Healthcare visionary Don Berwick draws from his decades of experience as a leading authority on health care system improvement to explain how Virta’s model can transform chronic disease care and bend the cost curve.
Steve Martin, former CEO of Blue Cross Blue Shield Nebraska, is a Virta patient and explains why Virta is the future of diabetes care
Dr. Smith explains how Virta's clinical evidence and patient testimonials took him from diabetes reversal skeptic to believer.
A new strategy toolkit to help benefits leaders evaluate solutions to address metabolic health, including sample RFP questions.
Virta Health and U-Haul International, Inc. announced 90-day outcomes from their partnership, including blood sugar reduction, weight loss, and medication deprescription.
2-year outcomes show transformative, long-lasting cardiometabolic health improvements for Veteran patients.
The HR Director talks about the financial value of diabetes reversal and why they now offer Virta's obesity treatment, too.
MPTN's Chief Medical Officer talks about the ROH (return on health) and ROI of Virta's treatment.
Former Chief Medical Officer Dr. Esser talks about changing and bettering the lives and well-being of patients with type 2 diabetes
ROI claims are as plentiful as the number of point solutions in digital health, so Virta’s research team recently undertook a study to understand the financial impacts of our diabetes reversal treatment using a claims-based analysis.
Validation Institute's analysis finds that Virta's diabetes reversal treatment drives estimated medication cost savings of nearly $6k per patient over 2 years.
Meet the leaders behind the heroic effort to reverse diabetes at WHA.
We use cookies on our site to give you the best experience possible. By continuing to browse the site, you agree to this use. For more information on how we use cookies, see our Privacy Policy.
